Barr Back In The Ring Over Plan B

Law360, New York (August 18, 2006, 12:00 AM EDT) -- Amid controversy surrounding Barr Pharmaceuticals Inc.’s move to make its morning after contraceptive pill available without a prescription, the drug maker has refiled its application with the U.S. Food and Drug Administration to sell Plan B over the counter to women over 18.

Barr—which makes Plan B through subsidiary Duramed Pharmaceuticals Inc.— submitted a revised application on Friday seeking federal approval to sell the Plan B "morning after" pill without a prescription, the FDA said.

Carol A. Cox, vice president of investor relations and corporate communications...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Tummino et al v. von Eschenbach


Case Number

1:05-cv-00366

Court

New York Eastern

Nature of Suit

Other Statutory Actions

Judge

Edward R. Korman

Date Filed

January 21, 2005

Government Agencies

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.